Welcome to BioSeeker Group!

Analytical Tool - Leukemia

Additional Information

Published Date Feb 21, 2012
Format PDF & Software Application
Publisher BioSeeker Group

Availability: In stock

€3,100.00

Quick Overview

A unique tool for analyzing the complex competitive pressure within the different fields of leukemia therapeutics.
Request free sample pages from Analytical Tool - Leukemia

"Analytical Tool - Leukemia" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market
and Leukemia Drug Pipeline Update 2012*
.


The Package Includes:

  • A progress analysis on current and emerging drugs
  • Information on most companies active in leukemia R&D
  • Information on key industry related leukemia projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs


This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of leukemia therapeutics
  • Identifying emerging leukemia products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of leukemia drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Request free sample pages from Analytical Tool - Leukemia

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Colorectal Cancer
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal R&D and business development. Learn More


Analytical Tool - Prostate Cancer
A unique tool for analyzing the complex competitive pressure within the field of prostate cancer. Learn More

Other selected research from the 'R&D' category:


TSH Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 135 companies plus partners who are today developing 182 TSH pathway targeting drugs in 551 developmental projects in cancer across 121 different targets. In addition, there are 2 suspended drugs and another 81 drugs where development has been ceased. Learn More


T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 197 companies plus partners who are today developing 221 T cell receptor pathway targeting drugs in 731 developmental projects in cancer across 130 different targets. In addition, there are 7 suspended drugs and another 129 drugs where development has been ceased. Learn More

Other selected research from the 'Oncology' category:


Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More


T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 197 companies plus partners who are today developing 221 T cell receptor pathway targeting drugs in 731 developmental projects in cancer across 130 different targets. In addition, there are 7 suspended drugs and another 129 drugs where development has been ceased. Learn More